CHRS Operating Income Growth
Coherus Oncology Inc · Operating Income Growth
CHRS Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-12.21%period ending
CHRS TTM Operating Income YoY % (-79.71% → -12.21%)
Year-over-year change
High-resolution chart · PNG
CHRS operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -12.211% | |
| -48.1536% | |
| -30.7495% | |
| -7.2206% | |
| 26.2427% | |
| 43.6251% | |
| 32.6133% | |
| 11.9486% | |
| 19.2217% | |
| 16.602% | |
| 20.8973% | |
| 24.1481% | |
| -18.7345% | |
| -37.3554% | |
| 2.6446% | |
| -17.8213% | |
| -39.5302% | |
| -241.7962% | |
| -268.7946% | |
| -212.4152% | |
| -169.629% | |
| -131.4153% | |
| 45.0514% | |
| 8,181.5495% | |
| 290.516% | |
| 192.3188% | |
| 152.7199% | |
| 101.1729% | |
| 43.9121% | |
| 11.2852% | |
| 11.9413% | |
| 26.5311% | |
| -61.1758% | |
| -62.7077% | |
| -100.2363% | |
| -173.6961% | |
| 52.9372% | |
| 49.7322% | |
| 47.0797% | |
| 51.0506% | |
| -94.76% | |
| -181.3663% | |
| -238.6831% | |
| -297.9099% | |
| -162.6682% | |
| -117.46% | |
| -79.7072% |